Investment Thesis
Bodhi Tree Biotechnology is a pre-revenue shell company with severe operational losses and negative cash flow, indicating it is not yet a functioning business. The company is rapidly burning cash despite minimal operations, with negative ROE and ROA suggesting shareholder value destruction. Without demonstrated revenue generation capability or clear path to profitability, this represents a speculative investment with substantial going concern risk.
Strengths
- Positive stockholders equity of $66.2K provides minimal equity cushion
- Low debt burden with zero long-term debt reduces leverage risk
- Cash position of $47.4K provides short-term runway for operations
Risks
- Zero revenue generation with no demonstrated business model or market traction
- Negative operating cash flow of -$62K indicates unsustainable cash burn rate
- Severely negative returns on equity (-80%) and assets (-76%) demonstrating value destruction
- Pre-revenue status suggests high risk of failure and capital depletion within 12-18 months at current burn rate
- No insider activity in past 90 days indicates lack of management confidence
Key Metrics to Watch
- Revenue generation and path to profitability
- Monthly cash burn rate and runway remaining
- Operating cash flow trend and improvement toward breakeven
- Form 4 filings indicating insider buying confidence
Financial Metrics
Revenue
0.0
Net Income
-52.9K
EPS (Diluted)
$-0.01
Free Cash Flow
-62.0K
Total Assets
69.7K
Cash
47.4K
Profitability Ratios
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
ROE
-80.0%
ROA
-76.0%
FCF Margin
N/A
Balance Sheet & Liquidity
Current Ratio
N/A
Quick Ratio
N/A
Debt/Equity
0.00x
Debt/Assets
5.0%
Interest Coverage
N/A
Long-term Debt
N/A
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-03-20T21:04:10.035621 |
Data as of: 2025-12-31 |
Powered by Claude AI